Journal article icon

Journal article

Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma

Abstract:

Background and purpose: To predict treatment-related cardiovascular disease (CVD) and second cancer 30-year absolute mortality risks (AMR30) for patients with mediastinal Hodgkin lymphoma in a large multicentre radiation oncology network in Ireland.

Material and methods: This study includes consecutive patients treated for mediastinal lymphoma using chemotherapy and involved site radiotherapy (RT) 2016–2019. Radiation dose...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s12094-022-03034-z

Authors


More by this author
Role:
Author
ORCID:
0000-0001-9199-460X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Role:
Author
ORCID:
0000-0001-7307-7488
Publisher:
Springer
Journal:
Clinical and Translational Oncology More from this journal
Volume:
25
Pages:
1368-1377
Publication date:
2022-12-31
Acceptance date:
2022-11-29
DOI:
EISSN:
1699-3055
ISSN:
1699-048X
Pmid:
36585562
Language:
English
Keywords:
Pubs id:
1318106
Local pid:
pubs:1318106
Deposit date:
2023-02-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP